Elvie raises £12.7m in a Series C extension to fund international expansion and product development.
The extension round includes backing from Blume Equity and existing investors to support the brand's growth.
Elvie develops smart technology for women's health and lifestyle, including a connected pelvic floor exercise tracker.
Elvie has secured £12.7m in a Series C extension round, bringing its total Series C funding to £70m. The latest investment was backed by the co-founders of Blume Equity alongside existing investors including IPGL, Hiro Capital and Westerly Winds. The newly raised capital will be directed towards product innovation, international expansion, and strengthening the company's operational infrastructure.
BGF previously led the initial Series C round for the femtech firm, which is scaling up its operations to serve as a comprehensive global platform for women's health. The company intends to use the funds to build on its portfolio of connected devices and widen its reach across new and existing markets.
From the founder
"Elvie is ready for the next phase of our growth. We have already revolutionized the categories we operate in, but we know that there is vast untapped potential to create better technology products and services for women in new areas."
Tania Boler
Co-Founder and CEO at Elvie
Use of funds
- 01Continue product development
- 02Expand into international markets
- 03Scale operations
- 04Build out infrastructure
